{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T11:00:01Z","timestamp":1777719601516,"version":"3.51.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35 GM131701"],"award-info":[{"award-number":["R35 GM131701"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Nebraska Research Initiative"},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA226436"],"award-info":[{"award-number":["R01 CA226436"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Chem Res"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s00044-026-03551-4","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T04:30:35Z","timestamp":1776054635000},"page":"814-833","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and evaluation of mitochondria-targeted caseinolytic protease (ClpP) agonist chemical probes in in vitro breast cancer models"],"prefix":"10.1007","volume":"35","author":[{"given":"Xiaoyu","family":"Hao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunjan","family":"Purohit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yahani P.","family":"Jayasinghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald R.","family":"Ronning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oleh","family":"Khalimonchuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul C.","family":"Trippier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"key":"3551_CR1","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.cell.2016.07.002","volume":"166","author":"S Vyas","year":"2016","unstructured":"Vyas S, Zaganjor E, Haigis MC. Mitochondria and cancer. Cell. 2016;166:555\u201366. https:\/\/doi.org\/10.1016\/j.cell.2016.07.002.","journal-title":"Cell"},{"key":"3551_CR2","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.molcel.2016.02.011","volume":"61","author":"WX Zong","year":"2016","unstructured":"Zong WX, Rabinowitz JD, White E. Mitochondria and cancer. Mol Cell. 2016;61:667\u201376. https:\/\/doi.org\/10.1016\/j.molcel.2016.02.011.","journal-title":"Mol Cell"},{"key":"3551_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.bbrc.2017.06.192","volume":"500","author":"DF Kashatus","year":"2018","unstructured":"Kashatus DF. The regulation of tumor cell physiology by mitochondrial dynamics. Biochem Biophys Res Commun. 2018;500:9\u201316. https:\/\/doi.org\/10.1016\/j.bbrc.2017.06.192.","journal-title":"Biochem Biophys Res Commun"},{"key":"3551_CR4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1053\/j.seminoncol.2014.03.007","volume":"41","author":"UE Martinez-Outschoorn","year":"2014","unstructured":"Martinez-Outschoorn UE, Lisanti MP. Tumor microenvironment: introduction. Semin Oncol. 2014;41:145. https:\/\/doi.org\/10.1053\/j.seminoncol.2014.03.007.","journal-title":"Semin Oncol"},{"key":"3551_CR5","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.ccell.2015.05.004","volume":"27","author":"A Cole","year":"2015","unstructured":"Cole A, Wang Z, Coyaud E, Voisin V, Gronda M, Jitkova Y, et al. Inhibition of the mitochondrial protease ClpP as a therapeutic strategy for human acute myeloid leukemia. Cancer Cell. 2015;27:864\u201376. https:\/\/doi.org\/10.1016\/j.ccell.2015.05.004.","journal-title":"Cancer Cell"},{"key":"3551_CR6","doi-asserted-by":"publisher","first-page":"e1002507","DOI":"10.1371\/journal.pbio.1002507","volume":"14","author":"JH Seo","year":"2016","unstructured":"Seo JH, Rivadeneira DB, Caino MC, Chae YC, Speicher DW, Tang HY, et al. the mitochondrial unfoldase-peptidase complex ClpXP controls bioenergetics stress and metastasis. PLoS Biol. 2016;14:e1002507. https:\/\/doi.org\/10.1371\/journal.pbio.1002507.","journal-title":"PLoS Biol"},{"key":"3551_CR7","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.ccell.2019.03.014","volume":"35","author":"J Ishizawa","year":"2019","unstructured":"Ishizawa J, Zarabi SF, Davis RE, Halgas O, Nii T, Jitkova Y, et al. Mitochondrial ClpP-mediated proteolysis induces selective cancer cell lethality. Cancer Cell. 2019;35:721\u201337.e9. https:\/\/doi.org\/10.1016\/j.ccell.2019.03.014.","journal-title":"Cancer Cell"},{"key":"3551_CR8","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1042\/bj3310309","volume":"331","author":"TJ Corydon","year":"1998","unstructured":"Corydon TJ, Bross P, Holst HU, Neve S, Kristiansen K, Gregersen N, et al. A human homologue of escherichia coli ClpP caseinolytic protease: recombinant expression, intracellular processing and subcellular localization. Biochem J. 1998;331:309\u201316. https:\/\/doi.org\/10.1042\/bj3310309.","journal-title":"Biochem J"},{"key":"3551_CR9","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1006\/jmbi.1999.3121","volume":"292","author":"MR de Sagarra","year":"1999","unstructured":"de Sagarra MR, Mayo I, Marco S, Rodriguez-Vilarino S, Oliva J, Carrascosa JL, et al. Mitochondrial localization and oligomeric structure of HClpP, the human homologue of E. coli ClpP. J Mol Biol. 1999;292:819\u201325. https:\/\/doi.org\/10.1006\/jmbi.1999.3121.","journal-title":"J Mol Biol"},{"key":"3551_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15467-7","volume":"11","author":"K Szczepanowska","year":"2020","unstructured":"Szczepanowska K, Senft K, Heidler J, Herholz M, Kukat A, Hohne MN, et al. A salvage pathway maintains highly functional respiratory complex I. Nat Commun. 2020;11:1643. https:\/\/doi.org\/10.1038\/s41467-020-15467-7.","journal-title":"Nat Commun"},{"key":"3551_CR11","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1038\/nm1306","volume":"11","author":"H Brotz-Oesterhelt","year":"2005","unstructured":"Brotz-Oesterhelt H, Beyer D, Kroll HP, Endermann R, Ladel C, Schroeder W, et al. Dysregulation of bacterial proteolytic machinery by a new class of antibiotics. Nat Med. 2005;11:1082\u20137. https:\/\/doi.org\/10.1038\/nm1306.","journal-title":"Nat Med"},{"key":"3551_CR12","doi-asserted-by":"publisher","first-page":"7193","DOI":"10.1016\/j.bmc.2010.08.032","volume":"18","author":"AM Socha","year":"2010","unstructured":"Socha AM, Tan NY, LaPlante KL, Sello JK. Diversity-oriented synthesis of cyclic acyldepsipeptides leads to the discovery of a potent antibacterial agent. Bioorg Med Chem. 2010;18:7193\u2013202. https:\/\/doi.org\/10.1016\/j.bmc.2010.08.032.","journal-title":"Bioorg Med Chem"},{"key":"3551_CR13","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1021\/acschembio.9b00347","volume":"14","author":"KS Wong","year":"2019","unstructured":"Wong KS, Houry WA. Chemical modulation of human mitochondrial ClpP: potential application in cancer therapeutics. ACS Chem Biol. 2019;14:2349\u201360. https:\/\/doi.org\/10.1021\/acschembio.9b00347.","journal-title":"ACS Chem Biol"},{"key":"3551_CR14","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1021\/acs.jmedchem.5b01451","volume":"59","author":"JD Goodreid","year":"2016","unstructured":"Goodreid JD, Janetzko J, Santa Maria JP Jr, Wong KS, Leung E, Eger BT, et al. Development and characterization of potent cyclic acyldepsipeptide analogues with increased antimicrobial activity. J Med Chem. 2016;59:624\u201346. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b01451.","journal-title":"J Med Chem"},{"key":"3551_CR15","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.chembiol.2018.05.014","volume":"25","author":"KS Wong","year":"2018","unstructured":"Wong KS, Mabanglo MF, Seraphim TV, Mollica A, Mao YQ, Rizzolo K, et al. Acyldepsipeptide analogs dysregulate human mitochondrial ClpP protease activity and cause apoptotic cell death. Cell Chem Biol. 2018;25:1017\u201330.e9. https:\/\/doi.org\/10.1016\/j.chembiol.2018.05.014.","journal-title":"Cell Chem Biol"},{"key":"3551_CR16","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1158\/0008-5472.CAN-23-2659","volume":"84","author":"Y Su","year":"2024","unstructured":"Su Y, Carter JL, Li X, Fukuda Y, Gray A, Lynch J, et al. The imipridone ONC213 targets alpha-ketoglutarate dehydrogenase to induce mitochondrial stress and suppress oxidative phosphorylation in acute myeloid leukemia. Cancer Res. 2024;84:1084\u2013100. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-2659.","journal-title":"Cancer Res"},{"key":"3551_CR17","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/j.chembiol.2020.08.006","volume":"27","author":"T Furukawa","year":"2020","unstructured":"Furukawa T, Katayama H, Oikawa A, Negishi L, Ichikawa T, Suzuki M, et al. Dioctatin activates ClpP to degrade mitochondrial components and inhibits aflatoxin production. Cell Chem Biol. 2020;27:1396\u2013409.e10. https:\/\/doi.org\/10.1016\/j.chembiol.2020.08.006.","journal-title":"Cell Chem Biol"},{"key":"3551_CR18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/emmm.200900002","volume":"1","author":"J Kirstein","year":"2009","unstructured":"Kirstein J, Hoffmann A, Lilie H, Schmidt R, Rubsamen-Waigmann H, Brotz-Oesterhelt H, et al. The antibiotic ADEP reprogrammes ClpP, switching it from a regulated to an uncontrolled protease. EMBO Mol Med. 2009;1:37\u201349. https:\/\/doi.org\/10.1002\/emmm.200900002.","journal-title":"EMBO Mol Med"},{"key":"3551_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2024.101015","volume":"55","author":"J Cao","year":"2024","unstructured":"Cao J, Cao F, Wang C, Jiao Z, You Y, Wang X, et al. ONC206 targeting ClpP induces mitochondrial dysfunction and protective autophagy in hepatocellular carcinoma cells. Neoplasia. 2024;55:101015. https:\/\/doi.org\/10.1016\/j.neo.2024.101015.","journal-title":"Neoplasia"},{"key":"3551_CR20","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.3390\/cancers15071936","volume":"15","author":"R Wedam","year":"2023","unstructured":"Wedam R, Greer YE, Wisniewski DJ, Weltz S, Kundu M, Voeller D, et al. Targeting mitochondria with ClpP agonists as a novel therapeutic opportunity in breast cancer. Cancers (Basel). 2023;15:1936. https:\/\/doi.org\/10.3390\/cancers15071936.","journal-title":"Cancers (Basel)"},{"key":"3551_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42784-4","volume":"14","author":"LL Zhou","year":"2023","unstructured":"Zhou LL, Zhang T, Xue Y, Yue C, Pan Y, Wang P, et al. Selective activator of human ClpP triggers cell cycle arrest to inhibit lung squamous cell carcinoma. Nat Commun. 2023;14:7069. https:\/\/doi.org\/10.1038\/s41467-023-42784-4.","journal-title":"Nat Commun"},{"key":"3551_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-021-00306-1","volume":"10","author":"YG Lee","year":"2021","unstructured":"Lee YG, Kim HW, Nam Y, Shin KJ, Lee YJ, Park DH, et al. LONP1 and ClpP cooperatively regulate mitochondrial proteostasis for cancer cell survival. Oncogenesis. 2021;10:18. https:\/\/doi.org\/10.1038\/s41389-021-00306-1.","journal-title":"Oncogenesis"},{"key":"3551_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03062-z","volume":"11","author":"K Nouri","year":"2020","unstructured":"Nouri K, Feng Y, Schimmer AD. Mitochondrial ClpP serine protease-biological function and emerging target for cancer therapy. Cell Death Dis. 2020;11:841. https:\/\/doi.org\/10.1038\/s41419-020-03062-z.","journal-title":"Cell Death Dis"},{"key":"3551_CR24","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1038\/s41375-019-0491-z","volume":"33","author":"T Nii","year":"2019","unstructured":"Nii T, Prabhu VV, Ruvolo V, Madhukar N, Zhao R, Mu H, et al. Imipridone ONC212 activates orphan G protein-coupled receptor GPR132 and integrated stress response in acute myeloid leukemia. Leukemia. 2019;33:2805\u201316. https:\/\/doi.org\/10.1038\/s41375-019-0491-z.","journal-title":"Leukemia"},{"key":"3551_CR25","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1158\/1535-7163.MCT-20-0962","volume":"20","author":"I Ferrarini","year":"2021","unstructured":"Ferrarini I, Louie A, Zhou L, El-Deiry WS. ONC212 is a novel mitocan acting synergistically with glycolysis inhibition in pancreatic cancer. Mol Cancer Ther. 2021;20:1572\u201383. https:\/\/doi.org\/10.1158\/1535-7163.MCT-20-0962.","journal-title":"Mol Cancer Ther"},{"key":"3551_CR26","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1124\/molpharm.121.000336","volume":"100","author":"RB Free","year":"2021","unstructured":"Free RB, Cuoco CA, Xie B, Namkung Y, Prabhu VV, Willette BKA, et al. Pharmacological characterization of the imipridone anticancer drug ONC201 reveals a negative allosteric mechanism of action at the D(2) dopamine receptor. Mol Pharmacol. 2021;100:372\u201387. https:\/\/doi.org\/10.1124\/molpharm.121.000336.","journal-title":"Mol Pharmacol"},{"key":"3551_CR27","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1146\/annurev.pharmtox.47.120505.105110","volume":"47","author":"MP Murphy","year":"2007","unstructured":"Murphy MP, Smith RA. Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu Rev Pharmacol Toxicol. 2007;47:629\u201356. https:\/\/doi.org\/10.1146\/annurev.pharmtox.47.120505.105110.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"3551_CR28","doi-asserted-by":"publisher","first-page":"2868","DOI":"10.1021\/acschembio.8b00423","volume":"13","author":"T Krainz","year":"2018","unstructured":"Krainz T, Lamade AM, Du L, Maskrey TS, Calderon MJ, Watkins SC, et al. Synthesis and evaluation of a mitochondria-targeting poly(ADP-ribose) polymerase-1 Inhibitor. ACS Chem Biol. 2018;13:2868\u201379. https:\/\/doi.org\/10.1021\/acschembio.8b00423.","journal-title":"ACS Chem Biol"},{"key":"3551_CR29","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1016\/j.bbamem.2013.03.027","volume":"1828","author":"LE Marbella","year":"2013","unstructured":"Marbella LE, Cho HS, Spence MM. Observing the translocation of a mitochondria-penetrating peptide with solid-state NMR. Biochim Biophys Acta. 2013;1828:1674\u201382. https:\/\/doi.org\/10.1016\/j.bbamem.2013.03.027.","journal-title":"Biochim Biophys Acta"},{"key":"3551_CR30","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.1074\/jbc.M110.186643","volume":"286","author":"LF Dong","year":"2011","unstructured":"Dong LF, Jameson VJ, Tilly D, Cerny J, Mahdavian E, Marin-Hernandez A, et al. Mitochondrial targeting of vitamin E succinate enhances its pro-apoptotic and anti-cancer activity via mitochondrial complex II. J Biol Chem. 2011;286:3717\u201328. https:\/\/doi.org\/10.1074\/jbc.M110.186643.","journal-title":"J Biol Chem"},{"key":"3551_CR31","doi-asserted-by":"publisher","first-page":"4846","DOI":"10.1039\/d3sc06445j","volume":"15","author":"ERH Walter","year":"2024","unstructured":"Walter ERH, Lee LC, Leung PK, Lo KK, Long NJ. Mitochondria-targeting biocompatible fluorescent BODIPY probes. Chem Sci. 2024;15:4846\u201352. https:\/\/doi.org\/10.1039\/d3sc06445j.","journal-title":"Chem Sci"},{"key":"3551_CR32","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1021\/acsmedchemlett.7b00320","volume":"8","author":"Y Li","year":"2017","unstructured":"Li Y, Lavey NP, Coker JA, Knobbe JE, Truong DC, Yu H, et al. Consequences of depsipeptide substitution on the ClpP activation activity of antibacterial acyldepsipeptides. ACS Med Chem Lett. 2017;8:1171\u20136. https:\/\/doi.org\/10.1021\/acsmedchemlett.7b00320.","journal-title":"ACS Med Chem Lett"},{"key":"3551_CR33","doi-asserted-by":"publisher","first-page":"6091","DOI":"10.1039\/c3an01152f","volume":"138","author":"G Cheng","year":"2013","unstructured":"Cheng G, Fan J, Sun W, Sui K, Jin X, Wang J, et al. A highly specific BODIPY-based probe localized in mitochondria for HClO imaging. Analyst. 2013;138:6091\u20136. https:\/\/doi.org\/10.1039\/c3an01152f.","journal-title":"Analyst"},{"key":"3551_CR34","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1021\/ar700135m","volume":"41","author":"AT Hoye","year":"2008","unstructured":"Hoye AT, Davoren JE, Wipf P, Fink MP, Kagan VE. Targeting mitochondria. Acc Chem Res. 2008;41:87\u201397. https:\/\/doi.org\/10.1021\/ar700135m.","journal-title":"Acc Chem Res"},{"key":"3551_CR35","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.celrep.2012.10.001","volume":"2","author":"Z Xun","year":"2012","unstructured":"Xun Z, Rivera-Sanchez S, Ayala-Pena S, Lim J, Budworth H, Skoda EM, et al. Targeting of XJB-5-131 to mitochondria suppresses oxidative DNA damage and motor decline in a mouse model of Huntington\u2019s disease. Cell Rep. 2012;2:1137\u201342. https:\/\/doi.org\/10.1016\/j.celrep.2012.10.001.","journal-title":"Cell Rep"},{"key":"3551_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.105210","volume":"299","author":"K Suzuki","year":"2023","unstructured":"Suzuki K, Kubota Y, Kaneko K, Kamata CC, Furuyama K. CLPX regulates mitochondrial fatty acid beta-oxidation in liver cells. J Biol Chem. 2023;299:105210. https:\/\/doi.org\/10.1016\/j.jbc.2023.105210.","journal-title":"J Biol Chem"},{"key":"3551_CR37","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/nsmb.1787","volume":"17","author":"BG Lee","year":"2010","unstructured":"Lee BG, Park EY, Lee KE, Jeon H, Sung KH, Paulsen H, et al. Structures of ClpP in complex with acyldepsipeptide antibiotics reveal its activation mechanism. Nat Struct Mol Biol. 2010;17:471\u20138. https:\/\/doi.org\/10.1038\/nsmb.1787.","journal-title":"Nat Struct Mol Biol"},{"key":"3551_CR38","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s10549-019-05324-7","volume":"177","author":"CV Grant","year":"2019","unstructured":"Grant CV, Carver CM, Hastings SD, Ramachandran K, Muniswamy M, Risinger AL, et al. Triple-negative breast cancer cell line sensitivity to englerin A identifies a new, targetable subtype. Breast Cancer Res Treat. 2019;177:345\u201355. https:\/\/doi.org\/10.1007\/s10549-019-05324-7.","journal-title":"Breast Cancer Res Treat"},{"key":"3551_CR39","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1021\/acschembio.9b00222","volume":"14","author":"PR Graves","year":"2019","unstructured":"Graves PR, Aponte-Collazo LJ, Fennell EMJ, Graves AC, Hale AE, Dicheva N, et al. Mitochondrial Protease ClpP is a target for the anticancer compounds ONC201 and related analogues. ACS Chem Biol. 2019;14:1020\u20139. https:\/\/doi.org\/10.1021\/acschembio.9b00222.","journal-title":"ACS Chem Biol"},{"key":"3551_CR40","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.3390\/cancers13092020","volume":"13","author":"Y Feng","year":"2021","unstructured":"Feng Y, Nouri K, Schimmer AD. Mitochondrial ATP-dependent proteases-biological function and potential anti-cancer targets. Cancers (Basel). 2021;13:2020. https:\/\/doi.org\/10.3390\/cancers13092020.","journal-title":"Cancers (Basel)"},{"key":"3551_CR41","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.cmet.2016.09.002","volume":"25","author":"S Guerrero-Castillo","year":"2017","unstructured":"Guerrero-Castillo S, Baertling F, Kownatzki D, Wessels HJ, Arnold S, Brandt U, et al. The assembly pathway of mitochondrial respiratory chain complex I. Cell Metab. 2017;25:128\u201339. https:\/\/doi.org\/10.1016\/j.cmet.2016.09.002.","journal-title":"Cell Metab"},{"key":"3551_CR42","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.15252\/embj.201694253","volume":"35","author":"K Szczepanowska","year":"2016","unstructured":"Szczepanowska K, Maiti P, Kukat A, Hofsetz E, Nolte H, Senft K, et al. CLPP coordinates mitoribosomal assembly through the regulation of ERAL1 levels. EMBO J. 2016;35:2566\u201383. https:\/\/doi.org\/10.15252\/embj.201694253.","journal-title":"EMBO J"},{"key":"3551_CR43","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1039\/d4md00733f","volume":"16","author":"LF Dow","year":"2025","unstructured":"Dow LF, Pathirage R, Erickson HE, Amani E, Ronning DR, Trippier PC. Synthesis and biological characterization of a 17beta hydroxysteroid dehydrogenase type 10 (17beta-HSD10) inhibitor. RSC Med Chem. 2025;16:862\u201375. https:\/\/doi.org\/10.1039\/d4md00733f.","journal-title":"RSC Med Chem"},{"key":"3551_CR44","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.chembiol.2011.07.023","volume":"18","author":"E Leung","year":"2011","unstructured":"Leung E, Datti A, Cossette M, Goodreid J, McCaw SE, Mah M, et al. Activators of cylindrical proteases as antimicrobials: identification and development of small molecule activators of ClpP protease. Chem Biol. 2011;18:1167\u201378. https:\/\/doi.org\/10.1016\/j.chembiol.2011.07.023.","journal-title":"Chem Biol"},{"key":"3551_CR45","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1021\/acsinfecdis.0c00599","volume":"6","author":"G Binepal","year":"2020","unstructured":"Binepal G, Mabanglo MF, Goodreid JD, Leung E, Barghash MM, Wong KS, et al. Development of antibiotics that dysregulate the neisserial ClpP protease. ACS Infect Dis. 2020;6:3224\u201336. https:\/\/doi.org\/10.1021\/acsinfecdis.0c00599.","journal-title":"ACS Infect Dis"},{"key":"3551_CR46","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1002\/pro.3590","volume":"28","author":"AJ Amor","year":"2019","unstructured":"Amor AJ, Schmitz KR, Baker TA, Sauer RT. Roles of the ClpX IGF loops in ClpP association, dissociation, and protein degradation. Protein Sci. 2019;28:756\u201365. https:\/\/doi.org\/10.1002\/pro.3590.","journal-title":"Protein Sci"},{"key":"3551_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-67010-1","volume":"17","author":"W Chen","year":"2026","unstructured":"Chen W, Lander GC, Yang J. Cryo-EM structures of human ClpXP reveal mechanisms of assembly and proteolytic activation. Nat Commun. 2026;17:1064. https:\/\/doi.org\/10.1038\/s41467-025-67010-1.","journal-title":"Nat Commun"},{"key":"3551_CR48","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1039\/c6np00125d","volume":"34","author":"IT Malik","year":"2017","unstructured":"Malik IT, Brotz-Oesterhelt H. Conformational control of the bacterial Clp protease by natural product antibiotics. Nat Prod Rep. 2017;34:815\u201331. https:\/\/doi.org\/10.1039\/c6np00125d.","journal-title":"Nat Prod Rep"},{"key":"3551_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.101781","volume":"298","author":"MF Mabanglo","year":"2022","unstructured":"Mabanglo MF, Houry WA. Recent structural insights into the mechanism of ClpP protease regulation by AAA+ chaperones and small molecules. J Biol Chem. 2022;298:101781. https:\/\/doi.org\/10.1016\/j.jbc.2022.101781.","journal-title":"J Biol Chem"},{"key":"3551_CR50","doi-asserted-by":"publisher","first-page":"5742","DOI":"10.1021\/ja051002s","volume":"127","author":"J Xiao","year":"2005","unstructured":"Xiao J, Weisblum B, Wipf P. Electrostatic versus steric effects in peptidomimicry: synthesis and secondary structure analysis of gramicidin S analogues with (E)-alkene peptide isosteres. J Am Chem Soc. 2005;127:5742\u20133. https:\/\/doi.org\/10.1021\/ja051002s.","journal-title":"J Am Chem Soc"},{"key":"3551_CR51","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1021\/op2002613","volume":"16","author":"EM Skoda","year":"2012","unstructured":"Skoda EM, Davis GC, Wipf P. Allylic amines as key building blocks in the synthesis of (E)-alkene peptide isosteres. Org Process Res Dev. 2012;16:26\u201334. https:\/\/doi.org\/10.1021\/op2002613.","journal-title":"Org Process Res Dev"}],"container-title":["Medicinal Chemistry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-026-03551-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00044-026-03551-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-026-03551-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:27:53Z","timestamp":1777458473000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00044-026-03551-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["3551"],"URL":"https:\/\/doi.org\/10.1007\/s00044-026-03551-4","relation":{},"ISSN":["1054-2523","1554-8120"],"issn-type":[{"value":"1054-2523","type":"print"},{"value":"1554-8120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"23 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}